Mitchell, Duane A <br/><br/>
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.  [electronic resource] 

 -  Cancer immunology research  Apr 2015 
 - 320-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2326-6074 
<br/><br/><label>Standard No.: </label>10.1158/2326-6066.CIR-14-0100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Autoantibodies--biosynthesis<br/>Cancer Vaccines--adverse effects<br/>Combined Modality Therapy<br/>Dacarbazine--adverse effects<br/>Dendritic Cells--immunology<br/>Glioblastoma--immunology<br/>Granulocyte-Macrophage Colony-Stimulating Factor--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Temozolomide